| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director | Director, Former 10% Owner
6 companies
Nashat Amir serves as a Director, 10% Owner at CAMP and has filed Form 4s across 6 companies. Across recent SEC filings that breaks down to 17 buys and 104 sells. Those positions are worth an estimated $864K at current prices.
Historically, Nashat Amir's trades have earned a below-average insider score of 44/100 across 3 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -1.0%.
The biggest single holding is FATE (~$483K) as Director. The recent filings there lean toward selling, a net 1,333,403 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | CAMP Camp4 Therapeutics Corp | Director, 10% Owner | Buy | 1,307,189 | $1.53 | $1,999,999.17 | -117.8% | +105.8% | - | |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | Director, 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | New | -63.3% | -68.0% | |
| Jun 22, 2022 | SRRK Scholar Rock Holding Corp | Director | Buy | 1,197,992 | $4.90 | $5,870,160.80 | -120.9% | +62.1% | +65.9% | |
| Aug 1, 2019 | FATE Fate Therapeutics Inc | Director | Sell | 62,005 | $22.53 | $1,397,066.29 | -84.9% | - | - | |
| Jul 30, 2019 | FATE Fate Therapeutics Inc | Director | Sell | 118,333 | $22.51 | $2,663,114.73 | -91.0% | - | - | |
| Jul 24, 2019 | FATE Fate Therapeutics Inc | Director | Sell | 81,899 | $22.51 | $1,843,150.96 | -86.5% | - | - | |
| Jul 22, 2019 | FATE Fate Therapeutics Inc | Director | Sell | 71,166 | $22.52 | $1,602,505.66 | -84.0% | - | - | |
| Jan 30, 2019 | FATE Fate Therapeutics Inc | Director | Sell | 53,017 | $14.16 | $750,959.30 | -3.5% | - | - | |
| Jan 29, 2019 | FATE Fate Therapeutics Inc | Director | Sell | 97,500 | $14.16 | $1,380,795.18 | -6.0% | - | - | |
| Jan 28, 2019 | FATE Fate Therapeutics Inc | Director | Sell | 70,000 | $13.78 | $964,768.00 | -4.1% | - | - |